Hoth Therapeutics Eulerpool News

Hoth Therapeutics Aktie News

Hoth Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Hoth Therapeutics News stellen wir hier zusammen.

• 10. Februar ·

  Benzinga
  EXCLUSIVE: Small Biotech Hoth Therapeutics Claims Experimental Obesity Drug Topped Famed Wegovy In Preclinical Study
• 10. Februar ·

  Benzinga
  EXCLUSIVE: Hoth Therapeutics Highlights HT/VA GDNF Data; Says In Head-To-Head Comparison Drug Demonstrated 'Superior Efficacy' Compared With Semaglutide Across Key Metrics
• 5. Februar ·

  Benzinga
  Hoth Therapeutics Advances HT-001 Clinical Trial, Expands Pipeline In Oncology And Obesity
• 21. Januar ·

  Benzinga
  Hoth Therapeutics shares are trading higher after the company announced that the China National Intellectual Property Administration has approved issuance of a key patent covering its HT-KIT cancer program.
• 4. Dezember ·

  Benzinga
  D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target
• 3. Dezember ·

  Yahoo
  Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program
• 1. Dezember ·

  Yahoo
  Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025
• 20. November ·

  Yahoo
  Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities
• 20. November ·

  Benzinga
  Hoth Therapeutics Joins NVIDIA Connect Program To Accelerate AI-Driven Drug Development
• 29. Oktober ·

  Yahoo
  2 Stocks to Buy Under $10 That Wall Street Loves

Hoth Therapeutics Aktie Pressemeldungen

Hoth Therapeutics publiziert auf der Unternehmenswebseite regelmäßig Meldungen, die für Investoren relevant sind.